RS4921914 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"[GWAS:None]"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| 5-acetylamino-6-formylamino-3-methyluracil levels | C | OR: 0.87 | 2E-542 | PubMed |
| N-acetylputrescine levels | C | OR: 0.54 | 2E-206 | PubMed |
| 5-acetylamino-6-amino-3-methyluracil levels | C | OR: 0.45 | 4E-143 | PubMed |
| 1-methylxanthine levels | T | β: 0.088 | 1E-60 | PubMed |
| Urine 4-acetamidobutanoate levels in chronic kidney disease | T | OR: 0.17 | 5E-59 | PubMed |
| Urine X-12410 levels in chronic kidney disease | T | OR: 0.33 | 2E-42 | PubMed |
| Urinary metabolites (H-NMR features) | T | OR: 0.51 | 4E-32 | PubMed |
| Urinary metabolites | C | — | 1E-28 | PubMed |
| CNTN3 protein levels | T | β: 0.062 | 2E-26 | PubMed |
| Tyrosine levels | T | β: 0.02 | 4E-24 | PubMed |
| Triglyceride levels | T | β: 0.035 | 2E-20 | PubMed |
| Phospholipids in medium HDL | T | β: 0.02 | 4E-20 | PubMed |
| mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed) | C | β: 0.03 | 5E-20 | PubMed |
| Urinary metabolite levels in chronic kidney disease | C | OR: 0.38 | 5E-18 | PubMed |
| N-acetylputrescine levels | — | OR: 0.85 | 6E-18 | PubMed |
| Monounsaturated fatty acids to total fatty acids percentage | C | — | 2E-17 | PubMed |
| Polyunsaturated fatty acids to monounsaturated fatty acids ratio | C | — | 1E-16 | PubMed |
| Total cholesterol levels | T | β: 0.03 | 1E-15 | PubMed |
| Omega-6 fatty acids to total fatty acids percentage | C | — | 3E-15 | PubMed |
| Total lipids in medium HDL | T | β: 0.02 | 2E-14 | PubMed |